Smad4 Haploinsufficiency in Mouse Models for Intestinal Cancer.
From: Department of Pathology, Josephine Nefkens Institute, ErasmusMC, Rotterdam, The Netherlands.
Oncogene
- Publish Date: Mar 2006
- ISSN: 0950-9232
- Volume: 25
- Issue: 13
- Pages: 1841-51
- Medium: Print
- Language: English
- Citation (JAMA): Alberici P, Jagmohan-Changur S, De Pater E, et al. Smad4 Haploinsufficiency in Mouse Models for Intestinal Cancer.. Oncogene Mar 2006;25:1841-51
Abstract
The Smad4(+/E6sad) mouse carries a null mutation in the endogenous Smad4 gene resulting in serrated adenomas and mixed polyposis of the upper gastrointestinal (GI) tract with 100% penetrance. Here, we show by loss of heterozygosity (LOH) analysis and immunohistochemistry (IHC) that, although the majority of the tumors appear at 9 months of age, somatic loss of the wild-type Smad4 allele occurs only at later stages of tumor progression. Hence, haploinsufficiency underlies Smad4-driven tumor initiation in the GI tract. As both the Apc and Smad4 tumor suppressor genes map to mouse chromosome 18, we have bred Smad4(+/E6sad) with the Apc(+/1638N) model to generate two distinct compound heterozygous lines carrying both mutations either in cis (CAS) or in trans (TAS). Strikingly, both models show increased tumor multiplicities when compared with the single mutant littermates, although CAS mice are more severely affected and became moribund at only 5-6 weeks of age. Phenotypic and molecular analyses indicate that Smad4 haploinsufficiency is sufficient to significantly affect tumor initiation and progression both prior to and upon loss of Apc function. Moreover, complete loss of Smad4 strongly enhances Apc-driven tumor formation.
Mesh Headings (Keywords): Age of Onset, Animals, DNA Mutational Analysis, Disease Progression, Genes, APC, Immunohistochemistry, Intestinal Neoplasms, Loss of Heterozygosity, Mice, Mice, Inbred C57BL, Phenotype, Signal Transduction, Smad4 Protein, Transforming Growth Factor beta, Wnt Proteins
Check for Full Text / PubMed Unique Identifier (PMID): 16288217
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.